These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2587 related items for PubMed ID: 17418153

  • 41. Use of 18F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions.
    Hart DP, Avivi I, Thomson KJ, Peggs KS, Morris EC, Goldstone AH, Linch DC, Ell PJ, Bomanji JB, Mackinnon S.
    Br J Haematol; 2005 Mar; 128(6):824-9. PubMed ID: 15755287
    [Abstract] [Full Text] [Related]

  • 42. Integrated FDG-PET-CT: its role in the assessment of bone and soft tissue tumors.
    Bischoff M, Bischoff G, Buck A, von Baer A, Pauls S, Scheffold F, Schultheiss M, Gebhard F, Reske SN.
    Arch Orthop Trauma Surg; 2010 Jul; 130(7):819-27. PubMed ID: 19636577
    [Abstract] [Full Text] [Related]

  • 43. Diagnostic performance of CT attenuation values of focal 18F-FDG avid breast lesions detected on whole-body PET-CT in postoperative breast cancer patients.
    Plaza MJ, Collado-Mesa F, Bokhoor J, Alperin N, Yepes MM.
    Breast J; 2014 Jul; 20(3):235-42. PubMed ID: 24750508
    [Abstract] [Full Text] [Related]

  • 44. Comparison of lesion-to-cerebellum uptake ratios and standardized uptake values in the evaluation of lung nodules with 18F-FDG PET.
    Obrzut S, Pham RH, Vera DR, Badran K, Hoha CK.
    Nucl Med Commun; 2007 Jan; 28(1):7-13. PubMed ID: 17159543
    [Abstract] [Full Text] [Related]

  • 45. (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
    Al-Ibraheem A, Buck AK, Benz MR, Rudert M, Beer AJ, Mansour A, Pomykala KL, Haller B, Juenger H, Scheidhauer K, Schwaiger M, Herrmann K.
    Cancer; 2013 Mar 15; 119(6):1227-34. PubMed ID: 23233156
    [Abstract] [Full Text] [Related]

  • 46. A unique presentation of appendicitis: F-18 FDG PET/CT.
    Koff SG, Sterbis JR, Davison JM, Montilla-Soler JL.
    Clin Nucl Med; 2006 Nov 15; 31(11):704-6. PubMed ID: 17053390
    [Abstract] [Full Text] [Related]

  • 47. Explicit incorporation of prior anatomical information into a nonrigid registration of thoracic and abdominal CT and 18-FDG whole-body emission PET images.
    Camara O, Delso G, Colliot O, Moreno-Ingelmo A, Bloch I.
    IEEE Trans Med Imaging; 2007 Feb 15; 26(2):164-78. PubMed ID: 17304731
    [Abstract] [Full Text] [Related]

  • 48. How do oncologists deal with incidental abnormalities on whole-body fluorine-18 fluorodeoxyglucose PET/CT?
    Wang G, Lau EW, Shakher R, Rischin D, Ware RE, Hong E, Binns DS, Hogg A, Drummond E, Hicks RJ.
    Cancer; 2007 Jan 01; 109(1):117-24. PubMed ID: 17133406
    [Abstract] [Full Text] [Related]

  • 49. F-18 FDG PET/CT characterization of talc pleurodesis-induced pleural changes over time: a retrospective study.
    Nguyen NC, Tran I, Hueser CN, Oliver D, Farghaly HR, Osman MM.
    Clin Nucl Med; 2009 Dec 01; 34(12):886-90. PubMed ID: 20139823
    [Abstract] [Full Text] [Related]

  • 50. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C, Gawande R, Uslu L, Khurana A, Qiu D, Quon A, Donig J, Rosenberg J, Luna-Fineman S, Moseley M, Daldrup-Link HE.
    Lancet Oncol; 2014 Mar 01; 15(3):275-85. PubMed ID: 24559803
    [Abstract] [Full Text] [Related]

  • 51. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
    Karantanis D, O'Neill BP, Subramaniam RM, Peller PJ, Witte RJ, Mullan BP, Wiseman GA.
    Clin Nucl Med; 2007 Apr 01; 32(4):271-4. PubMed ID: 17413571
    [Abstract] [Full Text] [Related]

  • 52. Determination of age-related changes in structure and function of skin, adipose tissue, and skeletal muscle with computed tomography, magnetic resonance imaging, and positron emission tomography.
    Wehrli NE, Bural G, Houseni M, Alkhawaldeh K, Alavi A, Torigian DA.
    Semin Nucl Med; 2007 May 01; 37(3):195-205. PubMed ID: 17418152
    [Abstract] [Full Text] [Related]

  • 53. FDG PET and PET/CT monitoring of autoimmune pancreatitis associated with extrapancreatic autoimmune disease.
    Nakajo M, Jinnouchi S, Noguchi M, Uozumi K, Tanabe H, Tateno R, Nakajo M.
    Clin Nucl Med; 2007 Apr 01; 32(4):282-5. PubMed ID: 17413574
    [Abstract] [Full Text] [Related]

  • 54. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
    Heusch P, Buchbender C, Beiderwellen K, Nensa F, Hartung-Knemeyer V, Lauenstein TC, Bockisch A, Forsting M, Antoch G, Heusner TA.
    Eur J Radiol; 2013 May 01; 82(5):870-6. PubMed ID: 23394765
    [Abstract] [Full Text] [Related]

  • 55. Monitoring cancer treatment with PET/CT: does it make a difference?
    Weber WA, Figlin R.
    J Nucl Med; 2007 Jan 01; 48 Suppl 1():36S-44S. PubMed ID: 17204719
    [Abstract] [Full Text] [Related]

  • 56. Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.
    Freudenberg LS, Schueler AO, Beyer T, Antoch G, Kühl H, Bornfeld N, Bockisch A, Egelhof T.
    Surv Ophthalmol; 2004 Jan 01; 49(5):537-40. PubMed ID: 15325198
    [Abstract] [Full Text] [Related]

  • 57. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
    Quon A, Fischbein NJ, McDougall IR, Le QT, Loo BW, Pinto H, Kaplan MJ.
    J Nucl Med; 2007 Jan 01; 48 Suppl 1():58S-67S. PubMed ID: 17204721
    [Abstract] [Full Text] [Related]

  • 58. Utility of PET/CT in differentiating benign from malignant adrenal nodules in patients with cancer.
    Vikram R, Yeung HD, Macapinlac HA, Iyer RB.
    AJR Am J Roentgenol; 2008 Nov 01; 191(5):1545-51. PubMed ID: 18941099
    [Abstract] [Full Text] [Related]

  • 59. Value of (18)F-FDG-PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experience.
    Federici L, Blondet C, Imperiale A, Sibilia J, Pasquali JL, Pflumio F, Goichot B, Blaison G, Weber JC, Christmann D, Constantinesco A, Andrès E.
    Int J Clin Pract; 2010 Jan 01; 64(1):55-60. PubMed ID: 18479364
    [Abstract] [Full Text] [Related]

  • 60. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.
    Pfannenberg C, Aschoff P, Schanz S, Eschmann SM, Plathow C, Eigentler TK, Garbe C, Brechtel K, Vonthein R, Bares R, Claussen CD, Schlemmer HP.
    Eur J Cancer; 2007 Feb 01; 43(3):557-64. PubMed ID: 17224266
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 130.